Medtronic is the largest medical technology company, offering an unprecedented breadth and depth of innovative therapies to fulfill its mission of alleviating pain, restoring health, and extending life. Medtronic has six main business units, which develop and manufacture devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down's syndrome, obesity, chronic pain, spinal disorders and diabetes.
Cardiac rhythm disease management is the oldest and largest of Medtronic's business units; spinal and biologics is Medtronic's second-largest business. Medtronic's cardiovascular therapies span the major specialities of interventional cardiology, cardiac surgery and vascular surgery. The products are used to reduce the potentially debilitating effects of coronary, aortic and structural heart disease. Neuromodulation is the second-oldest and third-largest department of Medtronic. Its products include neurostimulation systems and implantable drug delivery systems for chronic pain, common movement disorders and urologic and gastrointestinal disorders. The surgical technologies business group designed and manufactured products for the diagnosis and treatment of ear, nose and throat (ENT) diseases and cranial, spinal and neurologic conditions. It also encompassed a surgical navigation division to design "StealthStation" systems, software and instruments for Computer Assisted Surgery (CAS) and a special intraoperative X-ray imaging system, known as the O-arm Imaging System.

Company Growth (employees)
Minneapolis, US
Size (employees)
88,000 (est)
Medtronic was founded in 1949 and is headquartered in Minneapolis, US

Key People at Medtronic

Omar Ishrak

Omar Ishrak

Chairman and CEO
Richard E. Kuntz

Richard E. Kuntz

Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Carol Surface

Carol Surface

SVP and Chief Human Resources Officer

Medtronic Office Locations

Medtronic has offices in Minneapolis, Dublin, Singapore, Moscow and in 50 other locations
Minneapolis, US (HQ)
710 Medtronic Parkway
Tolochenaz, CH
Route Du Molliau 31, Case Postale
Mumbai, IN
#1241, Solitaire Corporate Park, Building 12, Ghatkopar Andheri Link Road, Andheri
Miami, US
Doral Corporate Centre Ii, 3750 Nw 87th Avenue, Suite 700
Beijing, CN
Beijing Rep. Office Suite 1805 1812 E1 Tower Oriental Plaza, No.1 East Chang An Ave., Dong Cheng District
Moscow, RU
Naberezhnaya Tower C, Presnenskaya Naberezhnaya,10
Show all (54)

Medtronic Data and Metrics

Medtronic Financial Metrics

Medtronic's revenue was reported to be $29.7 b in FY, 2017 which is a 3% increase from the previous period.

Revenue (FY, 2017)

29.7 b

Revenue growth (FY, 2016 - FY, 2017), %


Gross profit (FY, 2017)

20.4 b

Gross profit margin (FY, 2017), %


Net income (FY, 2017)

4 b

EBIT (FY, 2017)

5.3 b

Market capitalization (19-Jul-2017)

116.4 b

Closing share price (19-Jul-2017)


Cash (28-Apr-2017)

5 b


137.4 b
Medtronic's current market capitalization is $116.4 b.
USDFY, 2014FY, 2015FY, 2016FY, 2017


17 b20.3 b28.8 b29.7 b

Revenue growth, %


Cost of goods sold

4.3 b6.3 b9.1 b9.3 b

Gross profit

12.7 b14 b19.7 b20.4 b

Gross profit Margin, %


Operating expense total

13.3 b


3.8 b5.3 b5.3 b

EBIT margin, %


Interest expense

108 m666 m1.4 b1.1 b

Interest income

(386 m)(431 m)(366 m)

Pre tax profit

4.6 b

Income tax expense

640 m811 m798 m578 m

Net Income

3.1 b2.7 b3.5 b4 b
USDY, 2014FY, 2015FY, 2016FY, 2017


13.2 m4.8 b186.4 m5 b

Accounts Receivable

17.1 m


1.7 b3.5 b3.5 b3.3 b

Current Assets

21.2 b30.8 b23.6 b24.9 b


2.4 b4.7 b4.8 b4.4 b


10.6 b40.5 b41.5 b38.5 b

Total Assets

37.9 b106.7 b99.8 b99.8 b

Accounts Payable

742 m1.6 b1.7 b1.7 b

Total Debt

11.9 b36.2 b31.2 b25.9 b

Current Liabilities

5.6 b9.2 b7.2 b14.2 b

Total Liabilities

49.4 b

Additional Paid-in Capital

29.6 b

Retained Earnings

19.9 b54.4 b53.9 b23.4 b

Total Equity

19.4 b53.2 b52.1 b50.4 b

Debt to Equity Ratio

0.6 x0.7 x0.6 x0.5 x

Debt to Assets Ratio

0.3 x0.3 x0.3 x0.3 x

Financial Leverage

2 x2 x1.9 x2 x
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

3.1 b2.7 b3.5 b4 b

Depreciation and Amortization

349 m1.3 b2.8 b2 b

Accounts Receivable

(70 m)(413 m)(435 m)(75 m)


(39 m)(282 m)(186 m)

Accounts Payable

(16.7 m)

Cash From Operating Activities

5 b3.4 b5.2 b6.9 b

Purchases of PP&E

(396 m)

Cash From Investing Activities

(3.6 b)(17.1 b)2.2 b(1.6 b)

Long-term Borrowings

(565 m)(1.3 b)(5.1 b)(863 m)

Cash From Financing Activities

(918 m)15.9 b(9.5 b)(3.3 b)

Interest Paid

394 m578 m1.3 b1.1 b

Income Taxes Paid

521 m632 m1.4 b1 b
USDY, 2017


25.8 x


20 x


337.6 k


0.5 x


0.3 x

Financial Leverage

2 x

Medtronic Operating Metrics

Medtronic's Patients Served was reported to be 65 m in FY, 2016
FY, 2014FY, 2015FY, 2016

Patents Issued

27 k53 k45 k



Patients Served

65 m

Medtronic Market Value History

Medtronic Median Salaries

Source: 602 public H-1B filings from Medtronic

Medtronic Online and Social Media Presence

Medtronic News and Updates

Medtronic Company Life and Culture

You may also be interested in